Karrison T - Search Results

1

Sizes of ruptured and unruptured aneurysms in relation to their sites and the ages of patients.

Weir B, Disney L, Karrison T. Weir B, et al. Among authors: karrison t. J Neurosurg. 2002 Jan;96(1):64-70. doi: 10.3171/jns.2002.96.1.0064. J Neurosurg. 2002. PMID: 11794606

2

Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study.

Michelassi F, Lee J, Rubin M, Fichera A, Kasza K, Karrison T, Hurst RD. Michelassi F, et al. Among authors: karrison t. Ann Surg. 2003 Sep;238(3):433-41; discussion 442-5. doi: 10.1097/01.sla.0000086658.60555.ea. Ann Surg. 2003. PMID: 14501509 Free PMC article.

3

Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage.

Macdonald RL, Rosengart A, Huo D, Karrison T. Macdonald RL, et al. Among authors: karrison t. J Neurosurg. 2003 Oct;99(4):644-52. doi: 10.3171/jns.2003.99.4.0644. J Neurosurg. 2003. PMID: 14567598 Clinical Trial.

4

Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer.

Stadler WM, Huo D, George C, Yang X, Ryan CW, Karrison T, Zimmerman TM, Vogelzang NJ. Stadler WM, et al. Among authors: karrison t. J Urol. 2003 Oct;170(4 Pt 1):1141-5. doi: 10.1097/01.ju.0000086829.74971.4a. J Urol. 2003. PMID: 14501711 Clinical Trial.

5

Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: report from an international workshop.

Karrison T, Archer KJ, Espinosa R 3rd, Wen M, Huo D. Karrison T, et al. Genes Chromosomes Cancer. 2002 Apr;33(4):346-61. doi: 10.1002/gcc.10041. Genes Chromosomes Cancer. 2002. PMID: 11921270 No abstract available.

6

Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors.

Dolan ME, Posner M, Karrison T, Radosta J, Steinberg G, Bertucci D, Vujasin L, Ratain MJ. Dolan ME, et al. Among authors: karrison t. Clin Cancer Res. 2002 Aug;8(8):2519-23. Clin Cancer Res. 2002. PMID: 12171878 Clinical Trial.

7

MET and phosphorylated MET as potential biomarkers in lung cancer.

Tretiakova M, Salama AK, Karrison T, Ferguson MK, Husain AN, Vokes EE, Salgia R. Tretiakova M, et al. Among authors: karrison t. J Environ Pathol Toxicol Oncol. 2011;30(4):341-54. doi: 10.1615/jenvironpatholtoxicoloncol.v30.i4.70. J Environ Pathol Toxicol Oncol. 2011. PMID: 22181983

8

A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.

Argiris A, Cohen E, Karrison T, Esparaz B, Mauer A, Ansari R, Wong S, Lu Y, Pins M, Dancey J, Vokes E. Argiris A, et al. Among authors: karrison t. Cancer Biol Ther. 2006 Jul;5(7):766-70. doi: 10.4161/cbt.5.7.2874. Epub 2006 Jul 2. Cancer Biol Ther. 2006. PMID: 16760642 Clinical Trial.

9

A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.

Posadas EM, Undevia S, Manchen E, Wade JL, Colevas AD, Karrison T, Vokes EE, Stadler WM. Posadas EM, et al. Among authors: karrison t. Cancer Biol Ther. 2007 Apr;6(4):490-3. doi: 10.4161/cbt.6.4.3831. Cancer Biol Ther. 2007. PMID: 17457044 Clinical Trial.

10

A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer.

Stadler WM, Cao D, Vogelzang NJ, Ryan CW, Hoving K, Wright R, Karrison T, Vokes EE. Stadler WM, et al. Among authors: karrison t. Clin Cancer Res. 2004 May 15;10(10):3365-70. doi: 10.1158/1078-0432.CCR-03-0404. Clin Cancer Res. 2004. PMID: 15161690 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results